The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1630
August 9, 2021
View Complete Issue         Table of Contents 2019 
Issue 1630
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
In Brief: Guillain-Barré Syndrome with the Johnson & Johnson COVID-19 Vaccine
August 9, 2021 (Issue: 1630)
On July 12, 2021, the FDA added a warning to the Fact Sheet for the Johnson & Johnson (Janssen) adenovirus-based COVID-19 vaccine about an increased risk of Guillain-Barré syndrome (GBS) following administration of the product.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1630
 


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.